BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3 AND Staging
1519 results:

  • 1. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
    Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
    BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Real-World Challenges of Managing Diffuse Large B-Cell lymphoma in a Developing Country.
    Iftikhar R; Ahmad U; Haider G; Mahmood H; Khan M; Masood M; Anwar N; Javed Q; Sajid N; Tariq R; Mehmod S; Haider J; Abro NA; Shahbaz S; Khokhar A; Khan ZA; Pervez H; Moosajee M; Aziz Z
    JCO Glob Oncol; 2024 Apr; 10():e2300386. PubMed ID: 38603657
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Additional Findings of 18 F-AIF-FAPI-42 PET/CT in a Patient With Mycosis Fungoides-Type Cutaneous T-Cell lymphoma : Comparisons With 18 F-FDG PET/CT.
    Liu G; Li Y; Du B; Cui Y; Li X
    Clin Nucl Med; 2024 May; 49(5):e199-e201. PubMed ID: 38465934
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pre-treatment [
    Chen J; Zhao Y
    Hematology; 2024 Dec; 29(1):2325317. PubMed ID: 38465661
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Texture analysis of 18F-FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement.
    Abenavoli EM; Linguanti F; Anichini M; Miele V; Mungai F; Palazzo M; Nassi L; Puccini B; Romano I; Sordi B; Sciagrà R; Simontacchi G; Vannucchi AM; Berti V
    Hematol Oncol; 2024 Mar; 42(2):e3261. PubMed ID: 38454623
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy.
    Choi W; Jia Y; Kwak J; Werner-Wasik M; Dicker AP; Simone NL; Storozynsky E; Jain V; Vinogradskiy Y
    JCO Clin Cancer Inform; 2024 Mar; 8():e2300241. PubMed ID: 38452302
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Epidemiological features and a survival nomogram for primary lymphoma of the male genital tract.
    Xie R; Mao Z; Xu X; Sun T
    Ann Hematol; 2024 May; 103(5):1687-1695. PubMed ID: 38424302
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis.
    Zhang KD; Jost E; Panse J; Herwartz R; Lindemann-Docter K; Jonigk D; Kricheldorf K; Köchel A; Sauerbrunn N; Brümmendorf TH; Koschmieder S; Isfort S
    Ann Hematol; 2024 Apr; 103(4):1149-1158. PubMed ID: 38336973
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Factors affecting survival in stage 2-3 colorectal cancer: a single-center retrospective study.
    Karahan M; Mulkut F; Okut G
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):615-621. PubMed ID: 38305605
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Follicular lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
    Sarro R; Bisig B; Guey B; Missiaglia E; Cairoli A; Omoumi P; Letovanec I; Ferry JA; Hasserjian RP; de Leval L
    Mod Pathol; 2024 Apr; 37(4):100440. PubMed ID: 38290600
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Long non-coding RNA small nucleolar RNA host gene 29 drives chronic myeloid leukemia progression via microRNA-483-3p/Casitas B-lineage lymphoma axis-mediated activation of the phosphoinositide 3-kinase/Akt pathway.
    Feng X; Yang L; Liu X; Liu M; Liu L; Liu J; Luo J
    Med Oncol; 2024 Jan; 41(2):60. PubMed ID: 38252204
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic value of circulating plasma cells detected by flow cytometry in newly diagnosed multiple myeloma patients: a systematic review and meta-analysis.
    Liu X; Wu F; Ye W; Deng J; Zhang M; Zhang C; Yu Q; Cao L; Gan S; Ma J
    BMJ Open; 2024 Jan; 14(1):e071548. PubMed ID: 38216195
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Clinical and pathological characteristics and prognosis analysis of gray zone lymphoma].
    Liu SZ; Zong XP; Cai WZ; He HJ; Ma ZX; Li JQ; Li CX; Wu DP
    Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(1):69-73. PubMed ID: 38178771
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of FDG PET/CT in Patients With lymphoma Treated With Chimeric Antigen Receptor T-Cell Therapy: Current Concepts.
    Murad V; Kohan A; Ortega C; Prica A; Veit-Haibach P; Metser U
    AJR Am J Roentgenol; 2024 Mar; 222(3):e2330301. PubMed ID: 38054958
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Metabolic tumour volume in Hodgkin lymphoma-A comparison between manual and AI-based analysis.
    Sadik M; Barrington SF; Trägårdh E; Saboury B; Nielsen AL; Jakobsen AL; Gongora JLL; Urdaneta JL; Kumar R; Edenbrandt L
    Clin Physiol Funct Imaging; 2024 May; 44(3):220-227. PubMed ID: 38011940
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
    Li J; Wang YC; Lin JY
    Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
    [No Abstract]    [Full Text] [Related]  

  • 17. [Progressively transformed germinal center-like follicular T-cell lymphoma:a clinicopathological analysis of 14 cases].
    Zheng YY; Xie JL; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1144-1150. PubMed ID: 37899321
    [No Abstract]    [Full Text] [Related]  

  • 18. Chemokine Receptor PET/CT Provides Relevant staging and Management Changes in Marginal Zone lymphoma.
    Duell J; Buck AK; Hartrampf PE; Schlötelburg W; Schneid S; Weich A; Dreher N; Lapa C; Kircher M; Higuchi T; Samnick S; Serfling SE; Raderer M; Rasche L; Einsele H; Topp MS; Kosmala A; Werner RA
    J Nucl Med; 2023 Dec; 64(12):1889-1894. PubMed ID: 37797975
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Efficacy and safety of TBI+rATG-based conditioning regimen for haploidentical allogeneic hematopoietic stem cell transplantation in 11 cases of chemotherapy-resistant advanced peripheral T-cell lymphoma].
    Xu R; Li S; Liu HX; Wei DL; Jiang Y; Wang JJ; Liu SS; Wang C; Zhu J
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):578-581. PubMed ID: 37749039
    [No Abstract]    [Full Text] [Related]  

  • 20. [Efficacy and safety of programmed death-1 inhibitor in the treatment of relapsed/refractory classical Hodgkin's lymphoma].
    Shan DD; Liu HM; Liu W; Huang WY; Lyu R; Deng SH; Yi SH; An G; Xu Y; Sui WW; Wang TY; Fu MW; Zhao YZ; Qiu LG; Zou DH
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):555-560. PubMed ID: 37749034
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 76.